Diese Studie enthält eine ausreichend große Teilnehmerzahl. Sie können sich hierfür nicht mehr an- oder abmelden.

Parkinson's disease (part E)

Ort der Studie

Study of an investigational compound that is being developed for the treatment of Parkinson’s disease

 

Besonderheiten (auf Englisch)

  • You must speak and understand English or Dutch to participate.
  • For this study we are looking for healthy males and females, between 18 and 50 years old who do not smoke.
  • Your Body Mass Index (BMI) is between 18.5 and 29.9 kg/m2 and your body weight is at least 50 kilograms. 
  • Males are only allowed to participate if you use sufficient contraception or have been sterilized.
  • Females are only allowed to participate in this study if you:  
    • Have been sterilized for at least 6 months before the screening (Essure® method is not allowed for this study)
    • Have been postmenopausal for at least 12 months (without menstrual periods).
  • To determine if you are suitable to participate in this study, you will undergo a medical screening visit.
  • You are only allowed to participate, if you did not participate in a drug study within the 60 days prior to the screening for this study.
  • You are willing to perform a pulmonary function test as part of the screening (separate visit) and during the study.
  • You are willing to undergo two lumbar punctures during the study.

Vergütung (auf Englisch)

You will receive a gross compensation of €3573,- for participation in any of the groups of Part E.

Travelling expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12 and a maximum of €160 (840 kilometers) per return, regardless of the mode of transportation.

 

Periode und Studie (auf Englisch)

For Part E, the study consists of 1 period during which you will stay in our research facility in Groningen for 19 days (18 nights). Finally, there will be a follow-up visit including a pulmonary function test between 4 and 10 days after discharge from the research facility.

Please note: it may happen that the pulmonary function test takes place on a day other than the follow-up visit.

You can find the exact dates of each group on our website. If the dates do change you will be notified as soon as possible.

 

Group E3d

19 Tage Aufenthalt

2 Dez 2020 bis einschl. 20 Dez 2020

Anmerkung

Follow-up between December 28 & 31 2020

Group E3e

19 Tage Aufenthalt

22 Dez 2020 bis einschl. 9 Jan 2021

Anmerkung

Nakeuring tussen 13 & 19 januari 2021

 

 

link2trials

© 2025 Link2Trials